These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34049335)

  • 1. Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
    Pirmoazen AM; Khurana A; Loening AM; Liang T; Shamdasani V; Xie H; El Kaffas A; Kamaya A
    Invest Radiol; 2022 Jan; 57(1):23-32. PubMed ID: 34049335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Fat Quantification by Ultrasound in Children: A Prospective Study.
    D'Hondt A; Rubesova E; Xie H; Shamdasani V; Barth RA
    AJR Am J Roentgenol; 2021 Oct; 217(4):996-1006. PubMed ID: 33438457
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative Ultrasound Assessment of Hepatic Steatosis.
    Kaliaev A; Chavez W; Soto J; Huda F; Xie H; Nguyen M; Shamdasani V; Anderson S
    J Clin Exp Hepatol; 2022; 12(4):1091-1101. PubMed ID: 35814521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Park SJ
    Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
    Jung J; Han A; Madamba E; Bettencourt R; Loomba RR; Boehringer AS; Andre MP; Erdman JW; O'Brien WD; Fowler KJ; Sirlin CB; Loomba R
    Radiology; 2022 Jul; 304(1):75-82. PubMed ID: 35348378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
    Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
    Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dimensional Convolutional Neural Network Using Quantitative US for Noninvasive Assessment of Hepatic Steatosis in NAFLD.
    Jeon SK; Lee JM; Joo I; Yoon JH; Lee G
    Radiology; 2023 Apr; 307(1):e221510. PubMed ID: 36594835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
    Paige JS; Bernstein GS; Heba E; Costa EAC; Fereirra M; Wolfson T; Gamst AC; Valasek MA; Lin GY; Han A; Erdman JW; O'Brien WD; Andre MP; Loomba R; Sirlin CB
    AJR Am J Roentgenol; 2017 May; 208(5):W168-W177. PubMed ID: 28267360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
    Lin SC; Heba E; Wolfson T; Ang B; Gamst A; Han A; Erdman JW; O'Brien WD; Andre MP; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1337-1345.e6. PubMed ID: 25478922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Ultrasound Biomarkers to Assess Nonalcoholic Fatty Liver Disease.
    Gao J; Zapata I; Chen J; Erpelding TN; Adamson C; Park D
    J Ultrasound Med; 2023 Aug; 42(8):1675-1688. PubMed ID: 36744595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of ultrasound hepatorenal index for the diagnosis of hepatic steatosis in children.
    Frankland MP; Dillman JR; Anton CG; Coley BD; Nasser MP; O'Hara SM; Li Y; Trout AT
    Pediatr Radiol; 2022 Jun; 52(7):1306-1313. PubMed ID: 35229183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard.
    Mu R; Xia YC; Zhu KY; Lu JY; Luo Q; Zhang L; Lin RK; Cai XB; Qu Y; Lu LG
    J Dig Dis; 2023 Dec; 24(12):691-701. PubMed ID: 37994615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
    Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
    PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
    Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Artificial Intelligence-Calculated Hepatorenal Index for Diagnosing Mild and Moderate Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease.
    Zsombor Z; Rónaszéki AD; Csongrády B; Stollmayer R; Budai BK; Folhoffer A; Kalina I; Győri G; Bérczi V; Maurovich-Horvat P; Hagymási K; Kaposi PN
    Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984470
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrasound Shear Wave Attenuation Imaging for Grading Liver Steatosis in Volunteers and Patients With Non-alcoholic Fatty Liver Disease: A Pilot Study.
    Yazdani L; Rafati I; Gesnik M; Nicolet F; Chayer B; Gilbert G; Volniansky A; Olivié D; Giard JM; Sebastiani G; Nguyen BN; Tang A; Cloutier G
    Ultrasound Med Biol; 2023 Oct; 49(10):2264-2272. PubMed ID: 37482477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
    Caussy C; Alquiraish MH; Nguyen P; Hernandez C; Cepin S; Fortney LE; Ajmera V; Bettencourt R; Collier S; Hooker J; Sy E; Rizo E; Richards L; Sirlin CB; Loomba R
    Hepatology; 2018 Apr; 67(4):1348-1359. PubMed ID: 29108123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
    Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
    Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Ultrasound Attenuation: An Ultrasound Attenuation Index for Liver Steatosis Assessment.
    Gatos I; Drazinos P; Yarmenitis S; Theotokas I; Koskinas J; Koullias E; Mitranou A; Manesis E; Zoumpoulis PS
    Ultrasound Q; 2022 Jun; 38(2):124-132. PubMed ID: 35353797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.
    Han A; Byra M; Heba E; Andre MP; Erdman JW; Loomba R; Sirlin CB; O'Brien WD
    Radiology; 2020 May; 295(2):342-350. PubMed ID: 32096706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.